CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is excited to announce the launch of its new Immune System Tissue Microarrays for the scientific ...
With respect to assay development, quality assurance and, ultimately, clinical adoption, the primary subject of this review, these advantages are critical. Implicit with these advantages, TMAs enable ...
Aperio Technologies, Inc. has launched TMALab II, the latest release of the company’s web-based digital pathology information management system, built specifically for researchers who use Tissue ...
Dublin, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The "China Microarray Market Size, Share, Forecast, & Trend Analysis by Product, Application, End User- Forecast to 2031" report has been added to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results